| Literature DB >> 28350051 |
Gea Oliveri Conti1, Aldo Eugenio Calogero2, Filippo Giacone2, Maria Fiore1, Martina Barchitta3, Antonella Agodi3, Margherita Ferrante1.
Abstract
Benzo(a)pyrene (BaP) is a carcinogenic polycyclic aromatic hydrocarbon for human tissues. Still today it is not fully investigated if BaP can affect negatively the male fertility through the BaP‑DNA adducts production. In the present study, BaP Tetrol I‑1 (TI‑1) and BaP Tetrol II‑2 (TII‑2) BaP‑DNA adducts were investigated in spermatozoa of a Sicilian male population. Semen samples from 86 volunteers in two eastern Sicilian cities (Regalbuto and Melilli) were collected. The quality of semen was evaluated in all samples according to the World Health Organization (WHO) guidelines. We analyzed BaP‑DNA adducts in extracted sperm cell DNA using the modified high‑performance liquid chromatography‑fluorescence method to detects both Tetrols. Differences between Tetrol levels were assessed by the Wilcoxon signed‑rank test and the Mann‑Whitney U test, as appropriate. Correlation between semen quality parameters and Tetrol concentrations were analyzed using the Spearman's correlation coefficient. Σ(TI‑1+TII‑2) were significantly higher in spermatozoa of volunteers from Regalbuto. Furthermore, a greater dispersion of the levels of adducts was observed in these specimens. TI‑1 adducts were higher than TII‑2 in Melilli samples (95% CI) and TII‑2 were higher than TI‑1 in Regalbuto semen samples (95% CI). A significant inverse correlation between sperm progressive motility and both TI‑1 and TII‑2 adducts was observed. The present study showed that BaP negatively affects male fertility by TI‑1 and TII‑2 DNA‑adduct production. These results suggest that DNA adducts could be used as biomarker to assess BaP exposure by air pollution. Further studies are needed to confirm if these findings could affect male fertility because of the growing impairment of this function observed in recent years.Entities:
Mesh:
Substances:
Year: 2017 PMID: 28350051 PMCID: PMC5428921 DOI: 10.3892/mmr.2017.6396
Source DB: PubMed Journal: Mol Med Rep ISSN: 1791-2997 Impact factor: 2.952
Figure 1.Map of the sampling locations.
Figure 2.UV and fluorescence chromatograms of Tetrol standards.
Figure 3.Fluorescence chromatogram of a spiked sample.
Distribution of conventional sperm parameters.
| Variables | Min | 25th | Median | 75th | Max |
|---|---|---|---|---|---|
| Sperm concentration (millions/ml) | 0.0 | 32.5 | 76.0 | 113.5 | 250.0 |
| Total sperm count (millions/ejaculate) | 0.0 | 95.6 | 204.0 | 350.0 | 825.0 |
| Progressive motility (%) | 1.0 | 24.0 | 33.0 | 42.0 | 62.0 |
| Normal forms (%) | 8.0 | 13.0 | 16.0 | 20.0 | 33.0 |
Distribution of Tetrol I-1 and Tetrol II-2 (n. Adduct/108 nucleotides).
| Variables | Min | 25th | Median | 75th | Max |
|---|---|---|---|---|---|
| Tetrol I-1 | 0,00100 | 0,00240 | 0,00540 | 0,05226 | 103,58500 |
| Tetrol II-2 | 0,00200 | 0,00731 | 0,01712 | 0,17862 | 52,67400 |
Figure 4.Tetrol I-1 confidence interval (IC 95%) by area of residence.
Figure 5.Tetrol II-2 confidence interval (IC 95%) by area of residence.
Correlation between conventional parameters and Tetrols.
| Tetrol I-1 | Tetrol II-2 | Sperm concentration | Progressive motility | MNP c | Normal forms | Total count | Age | Cigarette/day | ||
|---|---|---|---|---|---|---|---|---|---|---|
| Tetrol I-1 | R | 1.000 | ||||||||
| P | . | |||||||||
| N | 86 | |||||||||
| Tetrol II-2 | R | 0.869[ | 1.000 | |||||||
| P | 0.000 | . | ||||||||
| N | 86 | 86 | ||||||||
| Sperm concentration | R | 0.077 | 0.022 | 1.000 | ||||||
| P | 0.480 | 0.840 | . | |||||||
| N | 86 | 86 | 86 | |||||||
| Progressive motility | R | −0.264[ | −0.222[ | 0.052 | 1.000 | |||||
| P | 0.014 | 0.040 | 0.502 | . | ||||||
| N | 86 | 86 | 86 | 86 | ||||||
| MNP c | R | 0.234[ | 0.279[ | 0.025 | −0.606[ | 1.000 | ||||
| P | 0.030 | 0.009 | 0.750 | 0.000 | . | |||||
| N | 86 | 86 | 86 | 86 | 86 | |||||
| Normal forms | R | 0.137 | 0.201 | 0.123 | 0.161[ | −0.015 | 1.000 | |||
| P | 0.209 | 0.063 | 0.109 | 0.035 | 0.848 | . | ||||
| N | 86 | 86 | 86 | 86 | 86 | 86 | ||||
| Total count | R | 0.061 | 0.042 | 0.820[ | 0.143 | −0.013 | 0.228[ | 1.000 | ||
| P | 0.579 | 0.702 | 0.000 | 0.063 | 0.866 | 0.003 | . | |||
| N | 86 | 86 | 86 | 86 | 86 | 86 | 86 | |||
| Age | R | −0.152 | −0.225[ | −0.006 | 0.041 | −0.060 | 0.021 | 0.056 | 1.000 | |
| P | 0.165 | 0.038 | 0.941 | 0.595 | 0.440 | 0.786 | 0.465 | . | ||
| N | 85 | 85 | 86 | 86 | 86 | 86 | 86 | 86 | ||
| Cigarette/day | R | 0.101 | 0.191 | 0.015 | 0.028 | 0.126 | 0.253[ | 0.143 | 0.358[ | 1.000 |
| P | 0.575 | 0.286 | 0.903 | 0.823 | 0.312 | 0.040 | 0.248 | 0.002 | . | |
| N | 40 | 40 | 40 | 40 | 40 | 40 | 40 | 40 | 40 |
Correlation is significant at the 0.05 level (two-tailed).
Correlation is significant at the 0.01 level (two-tailed). R, Spearman's rank correlation; P, P-value; N, number of men.